M.C.Shroff Pharmaceuticals Limited
About M.C.Shroff Pharmaceuticals Limited
Data last updated:
M.C.Shroff Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the financial auxiliary services segment of the financial services sector. It was incorporated on 24 January 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U67120MH1994PLC076216.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Swati Ramesh Shroff and Ramesh Menghraj Shroff.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 106 Kamal Bldg. C Bldg. Agarwal Market Vile Parle, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹36,250, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4,493 (net margin -12.4%) and EBITDA of -₹4,493 (EBITDA margin -12.4%). Revenue has declined at a compounded annual rate (CAGR) of 67% over three years.
Court records list 4 cases involving the company, including 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
M.C.Shroff Pharmaceuticals has one previous CIN (Corporate Identification Number): U67120MH1994PTC076216. The current CIN is U67120MH1994PLC076216, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U67120MH1994PLC076216 | Current |
| U67120MH1994PTC076216 | Previous |
Contact details
M.C.Shroff Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address106 Kamal Bldg. C Bldg. Agarwal Market Vile Parle, Mumbai, Maharashtra, India – 400057
- IndustryFinancial Services, Auxiliary To Financial Intermediatory
To see the full contact details of M.C.Shroff Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of M.C.Shroff Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of M.C.Shroff Pharmaceuticals Limited
FY 2025 filings availableM.C.Shroff Pharmaceuticals Limited reported revenue of ₹36,250 (up 304% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 304% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 67%. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4,493 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,493 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.4% | ||||
| Net Profit Margin | -12.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of M.C.Shroff Pharmaceuticals Limited, buy the company report.
Board of directors of M.C.Shroff Pharmaceuticals Limited
M.C.Shroff Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swati Ramesh Shroff | Director | 10 Aug 2018 | 8 Years 2 Months | Current |
| Ramesh Menghraj Shroff | Director | 24 Jan 1994 | 32 Years 9 Months | Current |
| Karan Ramesh Shroff | Director | 10 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
M.C.Shroff Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mizzle Drugs and Pharmaceuticals Private Limited | ₹37,736 (FY 2018) | -57.0% | Madurai, Tamil Nadu, India | |||
| Tutelage Pharmaceuticals Private Limited | ₹37,500 (FY 2021) | Bareilly, Uttar Pradesh, India | ||||
| M.C.Shroff Pharmaceuticals Limitedthis company | ₹36,250 (FY 2025) | -₹4,493 | -12.4% | 304.0% | Mumbai, Maharashtra, India | |
| Beatus Pharmaceuticals Private Limited | ₹34,982 (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India | |||
| MPDB Pharmaceuticals Private Limited | ₹34,545 (FY 2022) | -85.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of M.C.Shroff Pharmaceuticals Limited, buy the company report.
Auditor
M.C.Shroff Pharmaceuticals Limited is audited by Ritesh Hibare and Company for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ritesh Hibare and Company | FY 2017 | 146653 |
Shareholding
The shareholding of M.C.Shroff Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of M.C.Shroff Pharmaceuticals Limited, buy the company report.
Legal cases
M.C.Shroff Pharmaceuticals Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by The Deputy Registrar of Companies | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Registrar of Company | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Dy. Registrar of Companies | Disposed |
To see the full case history of M.C.Shroff Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for M.C.Shroff Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for M.C.Shroff Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
M.C.Shroff Pharmaceuticals Limited has 7 board changes on record since 1994: 3 appointments and 4 cessations. The latest: Karan Ramesh Shroff ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
M.C.Shroff Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in auxiliary to financial intermediatory, within the financial services industry. It was incorporated on 24 January 1994 (32+ years old) and is registered under CIN U67120MH1994PLC076216.
M.C.Shroff Pharmaceuticals has 3 current directors:
- Swati Ramesh Shroff - Director
- Ramesh Menghraj Shroff - Director
- Karan Ramesh Shroff - Director
The latest financial statements of M.C.Shroff Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of M.C.Shroff Pharmaceuticals is U67120MH1994PLC076216. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
M.C.Shroff Pharmaceuticals has 4 court cases on record: 4 filed against it.
M.C.Shroff Pharmaceuticals was incorporated on 24 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of M.C.Shroff Pharmaceuticals by revenue are Mizzle Drugs and Pharmaceuticals Private Limited, Tutelage Pharmaceuticals Private Limited, Beatus Pharmaceuticals Private Limited, MPDB Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Karan Ramesh Shroff ceased to be Additional Director on 29 Sep 2018. Swati Ramesh Shroff ceased to be Additional Director on 29 Sep 2018. Karan Ramesh Shroff was appointed as Director on 10 Aug 2018. M.C.Shroff Pharmaceuticals has 7 board changes on record in total.
The registered office of M.C.Shroff Pharmaceuticals is at 106 Kamal Bldg. C Bldg. Agarwal Market Vile Parle, Mumbai, Maharashtra, India – 400057.
M.C.Shroff Pharmaceuticals operates in the financial services industry, in the auxiliary to financial intermediatory segment.
The compliance status of M.C.Shroff Pharmaceuticals is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.